WHA Resolution Coalition Webinar: Turning the WHA Resolution on rare diseases into action
On 28 August 2025
At : Online
On 28 August 2025
At : Online
From 29 to 30 August 2025
At : Milan, Italy
On 11 September 2025
At : Online
From 16 to 17 September 2025
At : Copenhagen, Denmark
From 18 to 19 September 2025
At : Paris, France
From 06 to 10 October 2025
At : Uppsala, Sweden
From 20 to 21 October 2025
At : Washington DC, USA
From 27 to 29 October 2025
At : Amsterdam, Netherlands
From 05 to 07 November 2025
At : Prague, Czech Republic
On 18 November 2025
At : Zurich, Switzerland
From 10 to 12 February 2026
At : Lisbon, Portugal
On 24 February 2026
At : Brussels, Belgium (hybrid)
From 02 to 04 June 2026
At : Prague, Czech Republic
From 29 September to 02 October 2026
At : Paris, France
The European Reference Networks often organise educational webinars and other online meetings for their members and/or other interested parties. Below is a list of some upcoming events that may be of interest to our readers:
2026 webinars
From 18 to 19 September 2025
At : Warsaw, Poland

ERDERA has opened the first round of submissions for their new Networking Support Scheme (NSS). This continuously open call supports the organisation of transnational networking events that promote knowledge sharing, research uptake and collaborations among clinicians, researchers, and patients/patient advocacy organisations. Eligible events will have a clear rare disease or rare cancer research focus and address both aims of the call: promoting knowledge exchange and supporting greater inclusionof underrepresented countries. Funding of up to €30,000 is available per networking event.
The NSS is a permanently open call from May 2025 onwards until funds are exhausted (anticipated in April 2029). Applications will be reviewed in six-monthly collection rounds. The next collection date is 1 September 2025. More information on event eligibility and submission procedures is available on ERDERA's website.

The French Foundation for Rare Diseases (Fondation Maladies Rares, FMR) and the K20 Association have launched a call for research projects on heterotopic calcifications and ossifications in inactivating PTH/PTHrP/Gsa/AMPc/PKA signaling disorders (iPPSD). This call aims to support one or more innovative, fundamental, translational or clinical research programs on this topic from any biomedical sciences discipline. The maximum financing available is €50,000 over a maximum duration of 24 months. The deadline to apply is 17 July 2025 at 17h00 CET. More information on eligibility criteria and the application procedure is available in the call text.

The FDA operates a number of programs which provide funding for rare disease research projects and organisations. A list of these programs is available here.
In addition to these programs, a list of current and open FDA rare disease funding can be found on the NIH Grants and Funding page.
The Society for the Study of Inborn Errors of Metabolism (SSIEM) is accepting applications for funding to support external international scientific meetings on inborn errors of metabolism. Applicants can request a maximum of €50,000 and must apply by 31 July 2025.
The Share4Rare project is currently accepting submissions for their 2025 call for research projects. This call seeks to support studies collecting either quantitative or qualitative data on a specific rare disease or group of diseases. Eligible projects can vary in nature, but may include:
The 2025 call will remain open until 31 August 2025. More information is available here.

The French Foundation for Rare Diseases (Fondation Maladies Rares, FMR) is currently accepting funding applications from projects which aim to identify new therapeutic molecules for rare diseases. Eligible projects should address one or more of the following stages of the drug discovery pipeline:
The maximum funding available per project is €40,000, and applications must be submitted before 4 September 2025 at 17h00 CET.

The French Foundation for Rare Diseases (Fondation Maladies Rares, FMR) and the ALBI France Association have launched a call for research projects on low phospholipid associated lithiasis (LPAC). The call provides for financial support of up to €30,000 over a maximum duration of 24 months. The application deadline is 11 September 2025 at 17h00 CET.
![]()
Orphanet is recruiting a medical writer to work on our encyclopedia of rare diseases with a start date of 01/04/2026. Consult the job listing for more information, and apply by sending your CV and cover letter to jobs.orphanet@inserm.fr.
![]()
Orphanet is recruiting a scientific project manager to work on rare disease data, in the context of the OD4RD2 and JARDIN Joint Action projects. Consult the job listing for more information, and apply by sending your CV and cover letter to jobs.orphanet@inserm.fr.
The ERN-Skin is recruiting a project manager to join their coordination team. Please find the job listing attached for more information.